GO
Loading...

Exact Sciences CEO: Medicare Spending & Cologuard Test

Monday, 7 Jan 2013 | 6:45 PM ET

Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.